-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES LEQEMBI IQLIK® (LECANEMAB-IRMB) SUBCUTANEOUS INJECTION AS AN INITIATION DOSE FOR EARLY ALZHEIMER'S DISEASE

Reuters·07/13/2026 21:36:59

Please log in to view news